Which of the following describes the rationale for administering vitamin K to every neonate()
A. Neonates don’t receive the clotting factor in utero.
B. The neonate lacks intestinal flora to make the vitamin.
C. It boosts the minimal level of vitamin K found in the neonate.
D. The drug prevents the development of phenylketonuria (PKU).